deflazacort 36 MG Oral Tablet
- RxCUI
- 1870958
- RxNorm name
- deflazacort 36 MG Oral Tablet
- Display name
- deflazacort 36 MG Oral Tablet
- Full name
- deflazacort 36 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Deflazacort | DEFLAZACORT | Zydus Pharmaceuticals (USA) Inc. | f99fde7c-91ac-4d67-bd76-2b18a1d31f7d | 2026-07-23 | Warnings, Adverse reactions | 1870958 |
| JAYTHARI | DEFLAZACORT | Zydus Pharmaceuticals (USA) Inc. | ced839ee-1131-45c6-9e38-cc81d85daf1c | 2026-07-23 | Warnings, Adverse reactions | 1870958 |
| Deflazacort | DEFLAZACORT | Upsher-Smith Laboratories, LLC | 40818600-3ff0-4c9c-8e31-2001425a7dc9 | 2026-07-06 | Warnings, Adverse reactions | 1870958 |
| Deflazacort | DEFLAZACORT | Aurobindo Pharma Limited | 77d7525d-89c9-4fde-a6a8-0a463fd6cfeb | 2026-06-01 | Warnings, Adverse reactions | 1870958 |
| Deflazacort | DEFLAZACORT | AvKARE | 459b75a2-3242-3048-e063-6394a90ab882 | 2025-12-10 | Warnings, Adverse reactions | 1870958 |
| Deflazacort | DEFLAZACORT | Sun Pharmaceutical Industries, Inc. | fb5350d5-ead1-41f4-8b25-0da0bd7fcffe | 2025-12-09 | Warnings, Adverse reactions | 1870958 |
| EMFLAZA | DEFLAZACORT | PTC Therapeutics, Inc. | 31b347d2-f156-4055-9d8f-7cf0df420296 | 2025-11-13 | Warnings, Adverse reactions | 1870958 |
| KYMBEE | DEFLAZACORT | Upsher-Smith Laboratories, LLC | 89365f9f-a7ae-40d3-aecc-e4add75d21c2 | 2025-07-17 | Warnings, Adverse reactions | 1870958 |
| Deflazacort | DEFLAZACORT | Amneal Pharmaceuticals NY LLC | 18518568-a40b-41cb-91ce-44fbb5557971 | 2025-06-16 | Warnings, Adverse reactions | 1870958 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 31b347d2-f156-4055-9d8f-7cf0df420296 | deflazacort 36 MG Oral Tablet | SCD | 21 | These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017 | 20251113 |
| 31b347d2-f156-4055-9d8f-7cf0df420296 | deflazacort 36 MG Oral Tablet | PSN | 21 | These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017 | 20251113 |
| 40818600-3ff0-4c9c-8e31-2001425a7dc9 | deflazacort 36 MG Oral Tablet | SCD | 6 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017 | 20250501 |
| 40818600-3ff0-4c9c-8e31-2001425a7dc9 | deflazacort 36 MG Oral Tablet | PSN | 6 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017 | 20250501 |
| 18518568-a40b-41cb-91ce-44fbb5557971 | deflazacort 36 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS . DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017 | 20250616 |
| 18518568-a40b-41cb-91ce-44fbb5557971 | deflazacort 36 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS . DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017 | 20250616 |
| f99fde7c-91ac-4d67-bd76-2b18a1d31f7d | deflazacort 36 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS DEFLAZACORT tablets, for oral use Initial U.S. Approval:2017 | 20251217 |
| f99fde7c-91ac-4d67-bd76-2b18a1d31f7d | deflazacort 36 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS DEFLAZACORT tablets, for oral use Initial U.S. Approval:2017 | 20251217 |
| fb5350d5-ead1-41f4-8b25-0da0bd7fcffe | deflazacort 36 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017 | 20251209 |
| fb5350d5-ead1-41f4-8b25-0da0bd7fcffe | deflazacort 36 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017 | 20251209 |
| ced839ee-1131-45c6-9e38-cc81d85daf1c | deflazacort 36 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI JAYTHARI (deflazacort) tablets, for oral use Initial U.S. Approval:2017 | 20250519 |
| ced839ee-1131-45c6-9e38-cc81d85daf1c | deflazacort 36 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI JAYTHARI (deflazacort) tablets, for oral use Initial U.S. Approval:2017 | 20250519 |
| 77d7525d-89c9-4fde-a6a8-0a463fd6cfeb | deflazacort 36 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017 | 20240613 |
| 77d7525d-89c9-4fde-a6a8-0a463fd6cfeb | deflazacort 36 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS. DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017 | 20240613 |
| 459b75a2-3242-3048-e063-6394a90ab882 | deflazacort 36 MG Oral Tablet | PSN | 1 | DEFLAZACORT tablets, for oral use These highlights do not include all the information needed to use DEFLAZACORT TABELTS safely and effectively. See full prescribing information for DEFLAZACORT TABELTS Initial U.S. Approval: 2017 | 20251210 |
| 459b75a2-3242-3048-e063-6394a90ab882 | deflazacort 36 MG Oral Tablet | SCD | 1 | DEFLAZACORT tablets, for oral use These highlights do not include all the information needed to use DEFLAZACORT TABELTS safely and effectively. See full prescribing information for DEFLAZACORT TABELTS Initial U.S. Approval: 2017 | 20251210 |
| 89365f9f-a7ae-40d3-aecc-e4add75d21c2 | deflazacort 36 MG Oral Tablet | PSN | 1 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYMBEE safely and effectively. See full prescribing information for KYMBEE. KYMBEE TM (deflazacort) tablets, for oral use Initial U.S. Approval: 2017 | 20250717 |
| 89365f9f-a7ae-40d3-aecc-e4add75d21c2 | deflazacort 36 MG Oral Tablet | SCD | 1 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYMBEE safely and effectively. See full prescribing information for KYMBEE. KYMBEE TM (deflazacort) tablets, for oral use Initial U.S. Approval: 2017 | 20250717 |